✦ LIBER ✦

Phase I Trial of First-Line Bortezomib/Thalidomide plus Chemotherapy for Induction and Stem Cell Mobilization in Patients with Multiple Myeloma

✍ Scribed by Badros, Ashraf; Goloubeva, Olga; Fenton, Robert; Rapoport, Aaron P.; Akpek, Gorgun; Harris, Carolynn; Ruehle, Kathleen; Westphal, Sandra; Meisenberg, Barry

Book ID: 119935924
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 181 KB
Volume: 7
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2006.n.061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib with thalidomide plus dexamet

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

✍ Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 276 KB

Cost-Effectiveness of Induction Treatmen

Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany

✍ van Beurden-Tan, C.; Rosiñol, L.; Diels, J.; Wirth, D.; Chirita, O.; Lahuerta, J 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Phase I/II trial assessing bendamustine

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma

✍ Berenson, James R.; Yellin, Ori; Bessudo, Alberto; Boccia, Ralph V.; Noga, Steph 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Plerixafor as First- and Second-Line Str

Plerixafor as First- and Second-Line Strategies for Autologous Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma

✍ Kevin W. Lor; Pieter J. Helmons; Helen Belew; James R. Lane; Edward D. Ball 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Hematopoietic stem cell mobilization wit

Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial

✍ Gupta, S; Zhou, P; Hassoun, H; Kewalramani, T; Reich, L; Costello, S; Drake, L; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 154 KB

Combined bendamustine, prednisolone and

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial

✍ Wolfram Pönisch; Marta Rozanski; Hartmut Goldschmidt; Franz Albert Hoffmann; Tho 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB